Connection
Jennifer Goldman to Vancomycin
This is a "connection" page, showing publications Jennifer Goldman has written about Vancomycin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.189 |
|
|
|
-
Tillman EM, Goldman JL. Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children. Paediatr Drugs. 2021 Jul; 23(4):373-380.
Score: 0.783
-
Burns AN, Goldman JL. A Moving Target-Vancomycin Therapeutic Monitoring. J Pediatric Infect Dis Soc. 2020 Sep 17; 9(4):474-478.
Score: 0.740
-
Goldman JL, Harrison CJ, Myers AL, Jackson MA, Selvarangan R. No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates. Pediatr Infect Dis J. 2014 Feb; 33(2):216-8.
Score: 0.468
-
Murphy ME, Tang Girdwood S, Goldman JL, Scheetz MH, Downes KJ. Precision dosing of vancomycin: in defence of AUC-guided therapy in children. J Antimicrob Chemother. 2021 09 15; 76(10):2494-2497.
Score: 0.198